The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) extends its heartfelt congratulations to the newly elected Members of the European Parliament (MEPs). As the key representative body for predominantly small and medium-sized innovative pharmaceutical companies in Europe, EUCOPE recognises the pivotal role MEPs play in shaping… read more
The Regulation on Substances of Human Origin (SoHO) has been officially adopted by the EU Institutions, following the European Parliament’s approval on 24 April and the formal adoption by the Council of the European Union on 27 May. The new Regulation aims to improve the… read more
In June 2024, the Cancer Patients Europe, the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), the European Society of Pathology and Lung Cancer Europe (LuCE) published a joint statement on increasing access to genomic testing, delivering on the ambitions of Europe’s Beating Cancer Plan. Over the past 10 years,… read more
On 16 May 2024, EUCOPE signed EURORDIS Open Letter #ActRare2024, during the Closing Plenary session of the 12th European Conference on Rare Diseases and Orphan Products (ECRD), organised in Brussels on 15-16 May 2024. The Open Letter is a result of, and informed by, the… read more
On 25 April 2024, EUCOPE signed a Joint Statement on the European Commission’s Initiative “Boosting Biotechnology and Biomanufacturing in the EU”, together with key industry associations and organisations representing biotechnology across sectors. While focusing on the entire biotech sector, the Communication recognises the important role… read more
On 24 April 2024, EUCOPE was officially announced as a member of the Critical Medicines Alliance (“Alliance”). The Alliance is a consultative mechanism which brings together relevant stakeholders to identify priorities for action and propose solutions to better prevent and combat shortages of medicines, and to… read more
On 24 April 2024, the European Parliament adopted the provisional agreement on the European Health Data Space (EHDS) Regulation. The compromise text was already endorsed by COREPER on 22 March, but still requires formal adoption by the Employment, Social Policy, Health and Consumer Affairs Council… read more
On 10 April 2024, the European Parliament adopted the two reports on the Revision of the EU General Pharmaceutical Legislation, namely the Directive on medicinal products for human use and the Regulation on authorisation and supervision of medicinal products for human use and governing rules… read more
In April 2024, the Alliance for Regenerative Medicines (ARM), the European Federation of Pharmaceutical Industries and Associations (EFPIA), the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), the European Association for Bioindustries (EuropaBio) and Vaccines Europe stated their shared and serious concerns over the workability of the… read more
On 20 March, the European Commission’s published the Communication on Building the future with nature: Boosting biotechnology and biomanufacturing in the EU, proposing a series of targeted actions to boost biotechnology and biomanufacturing in the EU. While focussing on the entire biotech sector, the Communication… read more
Keep up-to-date on all of the most pertinent policy files and regulatory news around the world of European health technologies with our monthly newsletter – the Innovation Eye-View
You are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
You are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
You are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
